middle.news
ReNerve takes NervAlign into India as quarterly sales hit $584,000
9:18am on Tuesday 17th of November, 2026 AEDT
•
Medical Devices
Read Story
ReNerve takes NervAlign into India as quarterly sales hit $584,000
9:18am on Tuesday 17th of November, 2026 AEDT
Key Points
First commercial NervAlign Nerve Cuff use in India
Bangalore procedure performed for an upper-extremity nerve repair
September-quarter sales reached a record $584,000
NetCentrix Ventures leading local commercialisation and distribution
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Renerve (ASX:RNV)
OPEN ARTICLE